EPO and systemic lupus erythematosus: The erythropoietin signaling pathway is significantly upregulated in CM-positive human and mouse plasma, whereas HMGB1, IL-17, and systemic lupus erythematosus in B-cell signaling pathways were significantly downregulated in CM-positive plasma of both species.